FDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer
FDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer Targeted Oncology
Regulatory Approvals
FDA Approves New Engineered Viral Immunotherapy for Patients with Treatment-Resistant Advanced Melanoma
The U.S. Food and Drug Administration today granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg), a genetically modified oncolytic viral therapy…
FDA approves Replimune melanoma drug previously rejected twice
FDA approves Replimune melanoma drug previously rejected twice STAT
FDA approves Moderna’s mRNA flu vaccine after initial pushback
FDA approves Moderna's mRNA flu vaccine after initial pushback CBS News
FDA Approves First mRNA Flu Vaccine For Older Adults
FDA Approves First mRNA Flu Vaccine For Older Adults Forbes